English | 简体中文 | 繁體中文 | 한국어
Share:
Esperite (ESP) announces that Genoma SA filed appeal to the decision ruled by the Swiss Court

Genoma has filed appeal to the decision of liquidation taken on May 4th 2017. Genoma considers this decision arbitrary due to the circumstances of the commercial and legal relationship with Premaitha.

Zutphen, The Netherlands, 19 May 2017

Genoma has concluded with Premaitha an agreement in March 15th 2015 for the supply of the genetic test Iona. The implementation of this contract implied significant investment specifically related to the use of the IONA Kits. Genoma represented 65% of Premaitha's business in 2015/16.

Genoma was forced to discontinue using the Premaitha Iona test some weeks after the serious legal claim against Premaitha's technology by Illumina (Patent Infringement). Premaitha has not been able to demonstrate that the Iona test doesn't infringe Illumina's patents.

Genoma blocked payments to Premaitha, a total of +€900k for several reasons:

  • A considerable amount has been claimed for failure in the supply;
  • Illumina sued Genoma for patent infringement because of the use of Premaitha's Iona;
  • Premaitha never offered valid support for defence despite they were selling a patent infringing product.

The British supplier sent several summons for payment and finally obtained a court decision ruling for the bankruptcy of Genoma officially on May 4th 2017. The official register was updated on the 9th of May 2017.

About ESPERITE
ESPERITE Group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and predictive medicine established in 2000.

To learn more about ESPERITE Group, or to book an interview with CEO Frederic Amar: +31 575 548 998 - ir@esperite.com or visit the websites at
www.esperite.com and www.genoma.com.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Esperite N.V. via Globenewswire

Copyright © Thomson Reuters 2017. All rights reserved.
Press Releases
Sequa Petroleum N.V. (the "Company") General Meeting Results 8 December 2017  
Dec 11, 2017 17:53 ET
Aker Solutions to Provide Subsea Production System for Aker BP's Ærfugl  
Dec 11, 2017 11:01 ET
Nokia appoints Joerg Erlemeier as Chief Operating Officer and member of the Nokia Group Leadership Team  
Dec 11, 2017 08:31 ET
Galapagos to enter NASDAQ Biotech Index  
Dec 11, 2017 07:30 ET
DNO Steps Up Production from Peshkabir Field in Kurdistan  
Dec 11, 2017 07:00 ET
Volta Finance Limited : Early Estimated Net Asset Value - November 2017  
Dec 8, 2017 18:32 ET
Eastman Board Increases Dividend for Eighth Consecutive Year  
Dec 8, 2017 06:23 ET
AIR Updates Insured Loss Estimates for Hurricane Maria  
Dec 7, 2017 07:03 ET
Verisk to Discuss Revenue Growth Drivers and Strong Capital Allocation Track Record at Investor Day on Thursday, December 7, 2017, in New York City  
Dec 7, 2017 05:13 ET
INGREDION ANNOUNCES EXECUTIVE LEADERSHIP CHANGES  
Dec 5, 2017 03:03 ET
More News >>
Copyright © 2017 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: